The Food and Drug Administration issued a warning about the condition on Friday, May 16. In 209 cases tracked by the FDA, many described intense itching that appeared within days and disrupted their ...

The FDA approved two natural food dyes and expanded approval of a third on Friday in line with HHS’ goal to eliminate ...

The US FDA’s commissioner, Marty Makary, made the announcement in an email to staff. Prasad comes to the FDA from the University of California at San Francisco. The Food and Drug Administration ...

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. GSK had expected to secure an FDA ...

The FDA chief has called into question whether the agency will approve and authorize the COVID-19 vaccine for winter. In August 2024, the U.S. Food and Drug Administration approved the updated ...

The meetings appear to be part of a broader effort at the FDA to use this technology to speed up the drug approval process. “Why does it take over 10 years for a new drug to come to market?” ...

Kennedy Jr.'s layoffs. Kennedy initially planned to cut 3,500 employees from the FDA. In team-wide meetings that started last week, multiple FDA employees said they were informed by their ...

"I am very concerned. I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America's youth," the FDA's Commissioner of Food and Drugs ...

Prasad has vocally criticized the Warp Speed effort, and Marks’ leadership, on his blog and the social media platform X, where he was often praised by now-FDA Commissioner Dr. Marty Makary for ...

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT systems and potentially accelerating its reviews of medical products.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...